New York, NY, United States of America

Scott D Edmondson

USPTO Granted Patents = 46 

 

 

Average Co-Inventor Count = 5.7

ph-index = 9

Forward Citations = 343(Granted Patents)


Location History:

  • New York, NY (US) (2006 - 2008)
  • New York, NJ (US) (2004 - 2012)
  • Concord, MA (US) (2018 - 2019)
  • Clark, NJ (US) (2010 - 2021)

Company Filing History:


Years Active: 2004-2021

where 'Filed Patents' based on already Granted Patents

46 patents (USPTO):

Title: The Innovative Journey of Scott D Edmondson: Pioneering Inventor in New York

Introduction:

Scott D Edmondson, a prolific inventor based in New York, NY, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 46 patents. His groundbreaking work in developing compounds for treating diabetes, hyperlipidemia, and thromboses has earned him recognition in the industry.

Latest Patents:

1. Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists: Edmondson's innovation in this patent involves compounds that are potent agonists of the GPR120 receptor, offering promising treatment options for diabetes, hyperlipidemia, obesity, NASH, and related conditions.

2. Factor XIa inhibitors: His work on selective Factor XIa inhibitors demonstrates his expertise in developing compounds to address thromboses, embolisms, and hypercoagulability, showcasing his commitment to improving patient outcomes.

Career Highlights:

Having worked at esteemed companies like Merck Sharp & Dohme Corporation and Merck & Company, Inc., Edmondson has honed his skills and expertise in pharmaceutical research and development. His innovative approach to drug discovery has paved the way for novel treatment options in critical disease areas.

Collaborations:

Throughout his career, Edmondson has collaborated with notable professionals in the field, including Cheng Zhu and Richard Berger. These collaborations have facilitated knowledge exchange and fostered a culture of innovation, leading to groundbreaking discoveries in pharmaceutical science.

Conclusion:

Scott D Edmondson's relentless pursuit of innovation in pharmaceutical research has positioned him as a trailblazer in the industry. His patents and collaborations underscore his dedication to advancing healthcare solutions and improving patient outcomes. As a visionary inventor, Edmondson continues to inspire the next generation of researchers and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…